1.
In-silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues as Dual Inhibitors Targeting Breast Cancer. AJPHS [Internet]. 2021 Jun. 30 [cited 2025 Oct. 16];11(2):2468-74. Available from: https://ajphs.com/index.php/ajphs/article/view/126